Biofourmis, a healthcare technology company based in Boston, MA, is revolutionizing the future of health beyond wearables. They are pioneering the use of advanced bio-sensing technologies and artificial intelligence (AI) to provide personalized and data-driven healthcare solutions.
One of Biofourmis' notable innovations is their wearable biosensor called Biovitals™. This device collects real-time physiological data such as heart rate, respiratory rate, and activity levels. However, what sets Biofourmis apart is their AI-powered analytics platform that processes this data to derive actionable insights.
For example, Biofourmis has developed an AI algorithm that can predict heart failure exacerbation up to 14 days in advance. By continuously monitoring vital signs and analyzing patterns, the algorithm can detect subtle changes that may indicate an impending heart failure event. This early warning system allows healthcare providers to intervene proactively and prevent hospitalizations.
Another remarkable application of Biofourmis' technology is in post-operative care. By monitoring patients' vital signs remotely, healthcare providers can ensure early detection of complications and provide timely interventions. This not only improves patient outcomes but also reduces the burden on healthcare systems by minimizing hospital readmissions.
Biofourmis' innovative solutions have garnered recognition and partnerships with leading healthcare organizations. They have collaborated with the American College of Cardiology to develop a digital therapeutics platform for managing heart failure patients. Additionally, they have partnered with Novartis to leverage their technology in clinical trials.
With their cutting-edge technology and data-driven approach, Biofourmis is rewriting the future of health by enabling proactive and personalized care. By going beyond wearables and leveraging AI, they are transforming how healthcare is delivered and improving patient outcomes.
- Biofourmis. (n.d.). Retrieved from https://biofourmis.com
- American College of Cardiology. (2020). Biofourmis and the American College of Cardiology Announce Collaboration to Develop Digital Therapeutics for Heart Failure Patients. Retrieved from https://www.acc.org/about-acc/press-releases/2020/05/15/09/21/biofourmis-and-the-american-college-of-cardiology-announce-collaboration-to-develop-digital-therapeutics-for-heart-failure-patients
- Novartis. (2020). Novartis and Biofourmis partner to develop a digital therapeutics platform for heart failure patients. Retrieved from https://www.novartis.com/news/media-releases/novartis-and-biofourmis-partner-develop-digital-therapeutics-platform-heart-failure-patients
How to Contact Us:
Address: 33 Arch St fl 17, Boston, MA 02109, USA
Call us: (617) 334-5441